These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 19886884)

  • 41. Topical antifungal drugs for the treatment of onychomycosis: an overview of current strategies for monotherapy and combination therapy.
    Baran R; Kaoukhov A
    J Eur Acad Dermatol Venereol; 2005 Jan; 19(1):21-9. PubMed ID: 15649187
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A multicentre, randomized, controlled study of the efficacy, safety and cost-effectiveness of a combination therapy with amorolfine nail lacquer and oral terbinafine compared with oral terbinafine alone for the treatment of onychomycosis with matrix involvement.
    Baran R; Sigurgeirsson B; de Berker D; Kaufmann R; Lecha M; Faergemann J; Kerrouche N; Sidou F
    Br J Dermatol; 2007 Jul; 157(1):149-57. PubMed ID: 17553051
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A multicenter, open-label study of the efficacy and safety of ciclopirox nail lacquer solution 8% for the treatment of onychomycosis in patients with diabetes.
    Seebacher C; Nietsch KH; Ulbricht HM
    Cutis; 2001 Aug; 68(2 Suppl):17-22. PubMed ID: 11665724
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A-Detail fact sheet (Canada). Ciclopirox 8% nail lacquer (Penlac).
    Skin Therapy Lett; 2005 Dec-2006 Jan; 10(10):suppl 1 p.. PubMed ID: 16518906
    [No Abstract]   [Full Text] [Related]  

  • 45. Hydration of nail plate: a novel screening model for transungual drug permeation enhancers.
    Chouhan P; Saini TR
    Int J Pharm; 2012 Oct; 436(1-2):179-82. PubMed ID: 22705091
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The use of topical therapies to treat onychomycosis.
    Gupta AK; Ryder JE; Baran R
    Dermatol Clin; 2003 Jul; 21(3):481-9. PubMed ID: 12956200
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy and tolerability of amorolfine 5% nail lacquer in combination with systemic antifungal agents for onychomycosis: A meta-analysis and systematic review.
    Feng X; Xiong X; Ran Y
    Dermatol Ther; 2017 May; 30(3):. PubMed ID: 28097731
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In-vitro permeability of the human nail and of a keratin membrane from bovine hooves: penetration of chloramphenicol from lipophilic vehicles and a nail lacquer.
    Mertin D; Lippold BC
    J Pharm Pharmacol; 1997 Mar; 49(3):241-5. PubMed ID: 9231338
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Different physicochemical properties of antimycotic agents are relevant for penetration into and through human nails.
    Neubert RH; Gensbügel C; Jäckel A; Wartewig S
    Pharmazie; 2006 Jul; 61(7):604-7. PubMed ID: 16889067
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Application of cosmetic nail varnish does not affect the antifungal efficacy of amorolfine 5% nail lacquer in the treatment of distal subungual toenail onychomycosis: results of a randomised active-controlled study and in vitro assays.
    Sigurgeirsson B; Ghannoum MA; Osman-Ponchet H; Kerrouche N; Sidou F
    Mycoses; 2016 May; 59(5):319-26. PubMed ID: 26867498
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Determination of the subungual antifungal activity of amorolfine after 1 month's treatment in patients with onychomycosis: comparison of two nail lacquer formulations.
    Mensing H; Polak-Wyss A; Splanemann V
    Clin Exp Dermatol; 1992 Sep; 17 Suppl 1():29-32. PubMed ID: 1458661
    [No Abstract]   [Full Text] [Related]  

  • 52. Development of topical therapeutics for management of onychomycosis and other nail disorders: a pharmaceutical perspective.
    Elsayed MM
    J Control Release; 2015 Feb; 199():132-44. PubMed ID: 25481439
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bilayered nail lacquer of terbinafine hydrochloride for treatment of onychomycosis.
    Shivakumar HN; Vaka SR; Madhav NV; Chandra H; Murthy SN
    J Pharm Sci; 2010 Oct; 99(10):4267-76. PubMed ID: 20737634
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ciclopirox nail lacquer topical solution 8%.
    Gupta AK
    Skin Therapy Lett; 2000; 6(1):1-5. PubMed ID: 11027420
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy of amorolfine nail lacquer for the prophylaxis of onychomycosis over 3 years.
    Sigurgeirsson B; Olafsson JH; Steinsson JT; Kerrouche N; Sidou F
    J Eur Acad Dermatol Venereol; 2010 Aug; 24(8):910-5. PubMed ID: 20028447
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A multicentre, randomised, parallel-group, double-blind, vehicle-controlled and open-label, active-controlled study (versus amorolfine 5%), to evaluate the efficacy and safety of terbinafine 10% nail lacquer in the treatment of onychomycosis.
    Blume-Peytavi U; Tosti A; Falqués M; Tamarit ML; Carreño C; Galván J; Tebbs V
    Mycoses; 2022 Apr; 65(4):392-401. PubMed ID: 34752667
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combination of oral terbinafine and topical ciclopirox compared to oral terbinafine for the treatment of onychomycosis.
    Avner S; Nir N; Henri T
    J Dermatolog Treat; 2005; 16(5-6):327-30. PubMed ID: 16428154
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Optimization of Drug Permeation from 8% Ciclopirox Cyclodextrin/Poloxamer-Soluble Polypseudorotaxane-Based Nail Lacquers.
    Cutrín-Gómez E; Conde-Penedo A; Anguiano-Igea S; Gómez-Amoza JL; Otero-Espinar FJ
    Pharmaceutics; 2020 Mar; 12(3):. PubMed ID: 32151015
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ciclopirox nail lacquer solution 8% in the 21st century.
    Gupta AK; Baran R
    J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S96-102. PubMed ID: 11051138
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ex vivo nail infection as an effective preclinical method for screening of new topical antifungals.
    Quatrin PM; Kaminski TFA; Berlitz SJ; Guerreiro ICK; Canto RFS; Fuentefria AM
    J Mycol Med; 2020 Jun; 30(2):100938. PubMed ID: 32111505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.